Abbott bioabsorbable stent 30-day success rate is 94%: Everolimus-eluting, bioabsorbable BVS coronary stent achieves 93.5% delivery success rate with no major adverse cardiac events or stent thrombosis at 30-day follow-up. Results of Abbott's ABSORB trial, for BVS use in single, de novo, native coronary vessels, were presented Oct. 24 at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C., by principal investigator John Ormiston, MD, Auckland City Hospital, New Zealand. The stent demonstrated 7% recoil - "very similar to the recoil of a metallic stent," Ormiston said. Raimund Erbel, MD, University Duisburg-Essen, Germany, cautioned that the durability of polymer stent radial strength remains a concern because the polymers degrade over time (1"The Gray Sheet" April 10, 2006, p. 16)...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Medtronic is teaming up with IRCAD North America to build high-tech training and education experiences for surgeons and medical professionals in cardiovascular, neuroscience, and minimally invasive surgical specialties. The move could also further position Medtronic to seize on the growing robotics
GE HealthCare launches bkActiv S series – part of the bkPortfolio family of Active Imaging systems.
